FDA approves first over-the-counter birth control pill

FDA approves first over-the-counter birth control pill

Statement from Beth Battaglino, CEO of RN-C, HealthyWomen, on access to oral birth control:

The FDA’s approval of the first over-the-counter (OTC) progestogen-only oral contraceptive, Opill, is an important step toward dramatically increasing access to birth control across the country. Reflecting the sturdy body of scientific proofHealthyWomen advocates access to over-the-counter hormonal contraceptives for women and those assigned female at birth and the right of all individuals to access comprehensive sexual and reproductive health services to make choices that meet their needs.

While some legislative approaches have increased access in some states, requirements such as disbursement at the pharmacy still remain barriers for many. Given the scientific evidence showing that access to OTC contraception can be accomplished safely, FDA approval will help mitigate barriers, allowing more people to control their reproductive futures, including avoiding unplanned pregnancies.

However, Opill must be accessible, an important factor in ensuring that women, especially those without health insurance, can access this new option.

HealthyWomen will continue to provide leadership through policy advocacy and consumer and healthcare provider education, and to support research related to innovative strategies to expand access, safety and affordability of hormonal contraceptives.

From articles on your site
  • Quick Facts: What You Need to Know About Birth Control ›
  • Tips for Choosing a Birth Control Method ›
  • Birth control side effects that aren’t normal ›
  • Birth control pills >
Related articles Around the web